Teligent Inc (NASDAQ:TLGT) has earned a consensus recommendation of “Hold” from the seven research firms that are presently covering the company, Marketbeat reports. Three equities research analysts have rated the stock with a sell rating, two have issued a hold rating and one has given a buy rating to the company. The average twelve-month price objective among analysts that have issued a report on the stock in the last year is $6.83.
Separately, Canaccord Genuity cut their price objective on Teligent from $4.00 to $3.50 and set a “hold” rating for the company in a report on Friday, March 2nd.
Several hedge funds and other institutional investors have recently made changes to their positions in the company. Voya Investment Management LLC lifted its holdings in shares of Teligent by 16.1% during the second quarter. Voya Investment Management LLC now owns 23,342 shares of the company’s stock valued at $214,000 after purchasing an additional 3,234 shares during the last quarter. Northern Trust Corp lifted its holdings in shares of Teligent by 2.3% during the second quarter. Northern Trust Corp now owns 565,682 shares of the company’s stock valued at $5,176,000 after purchasing an additional 12,758 shares during the last quarter. Elk Creek Partners LLC lifted its holdings in shares of Teligent by 0.9% during the third quarter. Elk Creek Partners LLC now owns 1,709,841 shares of the company’s stock valued at $11,473,000 after purchasing an additional 15,087 shares during the last quarter. Schwab Charles Investment Management Inc. lifted its holdings in shares of Teligent by 26.1% during the fourth quarter. Schwab Charles Investment Management Inc. now owns 74,300 shares of the company’s stock valued at $270,000 after purchasing an additional 15,400 shares during the last quarter. Finally, Parametric Portfolio Associates LLC lifted its holdings in shares of Teligent by 85.6% during the second quarter. Parametric Portfolio Associates LLC now owns 34,549 shares of the company’s stock valued at $316,000 after purchasing an additional 15,933 shares during the last quarter. 68.36% of the stock is owned by institutional investors and hedge funds.
COPYRIGHT VIOLATION WARNING: “Teligent Inc (TLGT) Given Average Rating of “Hold” by Analysts” was originally published by American Banking News and is owned by of American Banking News. If you are viewing this story on another site, it was stolen and reposted in violation of US and international copyright & trademark law. The legal version of this story can be accessed at https://www.americanbankingnews.com/2018/03/13/teligent-inc-tlgt-given-average-rating-of-hold-by-analysts.html.
Teligent, Inc is a specialty generic pharmaceutical company. Under the Company’s own label, it markets and sells generic injectable pharmaceutical products in the United States and Canada. In the United States it marketed 16 generic topical pharmaceutical products and four branded generic pharmaceutical products, as of December 31, 2016.
Receive News & Ratings for Teligent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teligent and related companies with MarketBeat.com's FREE daily email newsletter.